The over-the-counter CGM market has two new players…the Lingo and Libre Rio. The two systems created by Abbott were intentionally designed to meet different needs – Lingo for those who want to better understand and improve their health and wellness, and Libre Rio for adults with type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.
read more →
Up until now, it’s been difficult for people newly diagnosed with type 2 diabetes, or those not on inulin, to get CGM covered by insurance. Thanks to the FDA’s recent approval of Dexcom Stelo – a CGM that can be purchased over-the-counter without a prescription – people with type 2 diabetes who are not on insulin will now be able to benefit from invaluable CGM technology.
read more →
Straight from the fashion hotspots of Paris, Milan, and TCOYD headquarters comes the first-ever Diabetes Device Fashion Show. Dr. E makes his supermodel debut while undressing – er, unveiling – several places on the body where it’s okay to stick your diabetes device.
read more →
Dr. E’s 84-year-old patient has had type 2 diabetes for 30 years and has been doing great on oral meds and basal insulin. At his last appointment though, his A1c was mysteriously high. How did Dr. E solve the problem?
read more →
Medicare made a big move recently and expanded CGM access for people with type 2 diabetes on insulin, or people with non-insulin treated diabetes who have a history of certain types of hypoglycemic events.
read more →
Dr. E has been wearing the Eversence E3 implantable CGM for about six weeks. He shares his thoughts on the insertion process, accuracy, ease of use, comfort, and the additional unique benefits of the system.
read more →
Watch Dr. E get the Eversense E3 CGM sensor inserted in real time! The E3 is the only fully-implantable sensor on the market, and it also has the longest wear time of any other sensor – 180 days! We’ll go through the features of the E3, the quick outpatient procedure, and important aftercare. (Emotional support teddy bears optional).
read more →
Even though we live in a continuously expanding diabetes tech age, we’re always excited when a product we love gets an upgrade. On December 8, 2022, Dexcom’s G7 CGM got the green light from the FDA. See what the next gen brings!
read more →
If you’re not utilizing your trend arrows and reacting to them, you’re not getting the most out of your CGM. Drs. E+P explain how to dose (or not dose) in response to the direction your trend arrows are pointing. Here’s their advice on how to adjust for highs and lows, along with a trend arrow cheat sheet.
read more →
Learn from Experts Who Live with Type 1 in Paradise–The Ultimate T1D Community Experience!
